|
|
 |
Home > Introduction to Company > Overview of
company |
|
|
 |
Insadol which was made to treat
gums for the first time in Korea was introduced in 1978.
This drug has been settled to be a people¡¯s drug showing
the sale of over 10 billion won. In addition to the above,
DONGKOOK produces superior medicines used favorably by
consumers such as Madecassol which is a drug for wounds,
Oramedy which is a drug for treating stomatitis, etc.
In 1992, DONGKOOK Pharm. Co. Ltd. constructed the prefilled
syringe system in its second factory (located at Kwanghyewon-myeon,
Jincheon-gun, Chungbuk) for the first time in Asia and produced a large amount of various kinds
of ultramodern injection agents. Located on its site are
its central research institute, raw material factory,
etc. where the raw materials of its main products are
extracted and synthesized directly.
Also, its third factory completed in 1994 is equipped
with ultramodern facilities and is by no means inferior
to other factories as the base of a leading company in
a new millennium. Particularly, DONGKOOK invests more
than 5% of the annual sale for research and development
expenses while operating its central research institute
centered on holders of master¡¯s degree and PhD.
|
|
|
|